Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 11 | 2021 | 3752 | 1.930 |
Why?
|
RNA, Small Interfering | 11 | 2019 | 3505 | 1.610 |
Why?
|
Nanoparticles | 12 | 2017 | 1905 | 1.410 |
Why?
|
Islets of Langerhans Transplantation | 10 | 2015 | 745 | 1.270 |
Why?
|
Doxorubicin | 5 | 2017 | 2234 | 1.200 |
Why?
|
Islets of Langerhans | 12 | 2017 | 1352 | 1.190 |
Why?
|
Molecular Imaging | 6 | 2017 | 828 | 1.150 |
Why?
|
Oligonucleotides | 3 | 2020 | 572 | 1.050 |
Why?
|
Magnetic Resonance Imaging | 24 | 2019 | 35421 | 0.800 |
Why?
|
Ferric Compounds | 5 | 2016 | 374 | 0.780 |
Why?
|
RNA Interference | 5 | 2021 | 2889 | 0.770 |
Why?
|
Magnetite Nanoparticles | 5 | 2019 | 321 | 0.730 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2017 | 1116 | 0.720 |
Why?
|
Cell Line, Tumor | 20 | 2021 | 16689 | 0.690 |
Why?
|
Pancreas | 5 | 2019 | 1686 | 0.680 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2019 | 137 | 0.650 |
Why?
|
Biosensing Techniques | 2 | 2016 | 668 | 0.650 |
Why?
|
Breast Neoplasms | 11 | 2021 | 20822 | 0.580 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2019 | 640 | 0.570 |
Why?
|
Mucin-1 | 6 | 2016 | 543 | 0.570 |
Why?
|
Drug Carriers | 2 | 2019 | 693 | 0.540 |
Why?
|
RNA-Induced Silencing Complex | 1 | 2016 | 55 | 0.540 |
Why?
|
Inhibitor of Apoptosis Proteins | 2 | 2013 | 215 | 0.520 |
Why?
|
Carbocyanines | 4 | 2017 | 174 | 0.510 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 713 | 0.500 |
Why?
|
Spectroscopy, Near-Infrared | 4 | 2009 | 721 | 0.490 |
Why?
|
Chickens | 3 | 2015 | 865 | 0.490 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2727 | 0.480 |
Why?
|
Mice | 42 | 2021 | 81183 | 0.460 |
Why?
|
Nanocapsules | 1 | 2014 | 91 | 0.450 |
Why?
|
Microscopy, Fluorescence | 9 | 2016 | 2699 | 0.450 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2021 | 3557 | 0.410 |
Why?
|
Adenocarcinoma | 5 | 2013 | 6364 | 0.400 |
Why?
|
Cell Movement | 3 | 2019 | 5217 | 0.400 |
Why?
|
Neoplastic Stem Cells | 1 | 2019 | 1376 | 0.400 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2015 | 692 | 0.400 |
Why?
|
Magnetics | 2 | 2012 | 606 | 0.390 |
Why?
|
Neoplasms, Experimental | 2 | 2014 | 1276 | 0.380 |
Why?
|
Animals | 49 | 2021 | 168757 | 0.370 |
Why?
|
Subrenal Capsule Assay | 1 | 2009 | 26 | 0.350 |
Why?
|
Pancreatic Neoplasms | 4 | 2019 | 5256 | 0.350 |
Why?
|
Oxides | 3 | 2009 | 405 | 0.340 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8428 | 0.330 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2010 | 3336 | 0.330 |
Why?
|
Spectrum Analysis, Raman | 1 | 2010 | 247 | 0.330 |
Why?
|
Drug Delivery Systems | 5 | 2017 | 2219 | 0.320 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1634 | 0.310 |
Why?
|
Neoplasms | 7 | 2020 | 21683 | 0.300 |
Why?
|
Isoantigens | 2 | 2015 | 567 | 0.300 |
Why?
|
Metal Nanoparticles | 1 | 2012 | 405 | 0.300 |
Why?
|
Disease Models, Animal | 10 | 2019 | 18029 | 0.300 |
Why?
|
Neoplasm Metastasis | 4 | 2019 | 4851 | 0.290 |
Why?
|
Iron | 5 | 2014 | 1774 | 0.280 |
Why?
|
Zinc | 1 | 2010 | 684 | 0.270 |
Why?
|
Gene Expression | 2 | 2016 | 7799 | 0.270 |
Why?
|
Nanostructures | 1 | 2010 | 551 | 0.270 |
Why?
|
Apoptosis | 6 | 2019 | 9727 | 0.260 |
Why?
|
Insulin-Secreting Cells | 2 | 2011 | 891 | 0.260 |
Why?
|
Brain Neoplasms | 4 | 2021 | 8863 | 0.250 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1086 | 0.250 |
Why?
|
Transplantation, Autologous | 1 | 2009 | 2124 | 0.240 |
Why?
|
Eimeria tenella | 1 | 2003 | 3 | 0.240 |
Why?
|
Coccidiosis | 1 | 2003 | 13 | 0.230 |
Why?
|
Poultry Diseases | 1 | 2003 | 25 | 0.230 |
Why?
|
Cecal Diseases | 1 | 2003 | 51 | 0.230 |
Why?
|
Immunotherapy | 1 | 2019 | 4445 | 0.230 |
Why?
|
Mice, Nude | 6 | 2016 | 3689 | 0.230 |
Why?
|
Peptides | 6 | 2012 | 4409 | 0.220 |
Why?
|
Mucins | 1 | 2006 | 564 | 0.220 |
Why?
|
Microcirculation | 1 | 2007 | 1286 | 0.220 |
Why?
|
Sarcoma, Avian | 1 | 2002 | 3 | 0.220 |
Why?
|
Cell Proliferation | 4 | 2021 | 10481 | 0.210 |
Why?
|
Fluorescence | 3 | 2017 | 751 | 0.200 |
Why?
|
Dextrans | 4 | 2015 | 595 | 0.200 |
Why?
|
Staining and Labeling | 1 | 2006 | 1100 | 0.200 |
Why?
|
Gene Silencing | 2 | 2010 | 1538 | 0.200 |
Why?
|
Contrast Media | 8 | 2016 | 5300 | 0.200 |
Why?
|
Fluorescent Dyes | 5 | 2017 | 1917 | 0.190 |
Why?
|
Histocompatibility Antigens | 1 | 2002 | 471 | 0.190 |
Why?
|
Hyperglycemia | 2 | 2008 | 1373 | 0.180 |
Why?
|
Models, Biological | 1 | 2017 | 9583 | 0.180 |
Why?
|
Gadolinium | 3 | 2012 | 952 | 0.180 |
Why?
|
Cell Survival | 3 | 2020 | 5882 | 0.180 |
Why?
|
Fluorescein-5-isothiocyanate | 2 | 2011 | 225 | 0.180 |
Why?
|
Diagnostic Imaging | 3 | 2009 | 3507 | 0.170 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11524 | 0.170 |
Why?
|
Drug Resistance, Multiple | 1 | 2020 | 252 | 0.170 |
Why?
|
Gadolinium DTPA | 2 | 2012 | 836 | 0.160 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6386 | 0.160 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3616 | 0.160 |
Why?
|
Molecular Probes | 3 | 2009 | 316 | 0.160 |
Why?
|
Liver Transplantation | 1 | 2009 | 2119 | 0.160 |
Why?
|
Graft Rejection | 4 | 2015 | 4397 | 0.160 |
Why?
|
Female | 26 | 2021 | 380194 | 0.160 |
Why?
|
Humans | 40 | 2021 | 744343 | 0.150 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 730 | 0.150 |
Why?
|
Flow Cytometry | 3 | 2014 | 5974 | 0.140 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 892 | 0.140 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2018 | 520 | 0.130 |
Why?
|
Avian Proteins | 1 | 2015 | 80 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2010 | 4479 | 0.130 |
Why?
|
Indocyanine Green | 1 | 2017 | 239 | 0.130 |
Why?
|
Deoxycytidine | 1 | 2019 | 826 | 0.130 |
Why?
|
Nanomedicine | 1 | 2017 | 304 | 0.120 |
Why?
|
Infrared Rays | 2 | 2005 | 249 | 0.120 |
Why?
|
Base Pairing | 1 | 2014 | 141 | 0.120 |
Why?
|
Luminescent Measurements | 1 | 2016 | 405 | 0.110 |
Why?
|
Cell-Free System | 1 | 2014 | 344 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 433 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1375 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13695 | 0.110 |
Why?
|
Mice, Inbred NOD | 5 | 2012 | 1878 | 0.110 |
Why?
|
Ribonucleases | 1 | 2014 | 287 | 0.110 |
Why?
|
Drug Monitoring | 1 | 2019 | 956 | 0.110 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6234 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 809 | 0.110 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2009 | 8949 | 0.110 |
Why?
|
Streptozocin | 2 | 2015 | 196 | 0.100 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6314 | 0.100 |
Why?
|
Chelating Agents | 2 | 2010 | 380 | 0.100 |
Why?
|
Biological Availability | 1 | 2012 | 397 | 0.100 |
Why?
|
Dacarbazine | 1 | 2014 | 566 | 0.100 |
Why?
|
Sphingomyelins | 1 | 2011 | 105 | 0.100 |
Why?
|
Salts | 1 | 2010 | 65 | 0.100 |
Why?
|
Mice, Transgenic | 3 | 2016 | 9734 | 0.090 |
Why?
|
Ferrosoferric Oxide | 2 | 2009 | 360 | 0.090 |
Why?
|
Drug Stability | 1 | 2010 | 291 | 0.090 |
Why?
|
DNA Repair | 1 | 2020 | 2046 | 0.090 |
Why?
|
Blotting, Western | 3 | 2012 | 5179 | 0.090 |
Why?
|
Fluorine Compounds | 1 | 2009 | 5 | 0.090 |
Why?
|
Fibrin | 1 | 2012 | 506 | 0.090 |
Why?
|
Particle Size | 1 | 2014 | 1642 | 0.090 |
Why?
|
Transfection | 2 | 2016 | 5892 | 0.090 |
Why?
|
Tumor Burden | 1 | 2015 | 1915 | 0.090 |
Why?
|
Major Histocompatibility Complex | 3 | 2012 | 936 | 0.080 |
Why?
|
Curcumin | 1 | 2009 | 96 | 0.080 |
Why?
|
Drug Design | 1 | 2014 | 1076 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2015 | 2958 | 0.080 |
Why?
|
Boron Compounds | 1 | 2009 | 178 | 0.080 |
Why?
|
Image Enhancement | 2 | 2010 | 2921 | 0.080 |
Why?
|
Mice, SCID | 3 | 2012 | 2716 | 0.080 |
Why?
|
Surface Properties | 1 | 2010 | 1184 | 0.080 |
Why?
|
Papio | 1 | 2009 | 656 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2012 | 21827 | 0.080 |
Why?
|
Lymphatic Metastasis | 2 | 2012 | 2924 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3521 | 0.080 |
Why?
|
Pentetic Acid | 1 | 2007 | 213 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11124 | 0.070 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6773 | 0.070 |
Why?
|
Cell Cycle | 1 | 2015 | 2967 | 0.070 |
Why?
|
Gold | 1 | 2010 | 484 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3586 | 0.070 |
Why?
|
Lymphocytes | 2 | 2015 | 2617 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 1655 | 0.070 |
Why?
|
Antigens | 1 | 2011 | 1466 | 0.070 |
Why?
|
Annexin A5 | 1 | 2005 | 103 | 0.060 |
Why?
|
Molecular Probe Techniques | 1 | 2006 | 119 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 3002 | 0.060 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2012 | 949 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2012 | 1101 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5172 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2012 | 2382 | 0.060 |
Why?
|
Cyclohexanes | 1 | 2005 | 152 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3922 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2017 | 11031 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 804 | 0.060 |
Why?
|
Liposomes | 1 | 2008 | 759 | 0.060 |
Why?
|
Optics and Photonics | 1 | 2006 | 321 | 0.060 |
Why?
|
Disease Progression | 2 | 2012 | 13284 | 0.060 |
Why?
|
Breast | 1 | 2012 | 1969 | 0.060 |
Why?
|
Immunologic Memory | 1 | 2010 | 1348 | 0.060 |
Why?
|
Amino Acid Sequence | 3 | 2010 | 13815 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 2088 | 0.060 |
Why?
|
Coloring Agents | 1 | 2005 | 566 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1442 | 0.050 |
Why?
|
Environmental Monitoring | 1 | 2009 | 1414 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5720 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 18111 | 0.050 |
Why?
|
Autoimmunity | 1 | 2010 | 1349 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2171 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11366 | 0.050 |
Why?
|
Angiography | 1 | 2007 | 1639 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8642 | 0.050 |
Why?
|
Fluorouracil | 1 | 2006 | 1619 | 0.050 |
Why?
|
Microscopy, Confocal | 4 | 2008 | 1970 | 0.050 |
Why?
|
Glioblastoma | 1 | 2014 | 3481 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 1017 | 0.040 |
Why?
|
Water | 1 | 2005 | 1395 | 0.040 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2645 | 0.040 |
Why?
|
Antibodies, Monoclonal | 3 | 2011 | 9274 | 0.040 |
Why?
|
Pyridines | 1 | 2010 | 2825 | 0.040 |
Why?
|
Rats | 2 | 2011 | 24260 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2006 | 1988 | 0.040 |
Why?
|
Graft Survival | 1 | 2008 | 3737 | 0.040 |
Why?
|
Blood Glucose | 2 | 2015 | 6256 | 0.040 |
Why?
|
Tissue Distribution | 2 | 2017 | 2327 | 0.040 |
Why?
|
Insulin | 2 | 2011 | 6580 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2016 | 19905 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16365 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2133 | 0.040 |
Why?
|
Amyloid beta-Peptides | 1 | 2009 | 3587 | 0.040 |
Why?
|
Indoles | 1 | 2005 | 1839 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2010 | 2988 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 3086 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1782 | 0.030 |
Why?
|
Papio hamadryas | 1 | 2015 | 29 | 0.030 |
Why?
|
Glycosylation | 2 | 2012 | 1126 | 0.030 |
Why?
|
Haplotypes | 1 | 2002 | 2779 | 0.030 |
Why?
|
Scorpion Venoms | 1 | 2014 | 31 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3401 | 0.030 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2014 | 85 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2016 | 63114 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5097 | 0.030 |
Why?
|
Kidney | 1 | 2009 | 7186 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2009 | 11725 | 0.030 |
Why?
|
Molecular Structure | 2 | 2009 | 1899 | 0.030 |
Why?
|
Weight Gain | 1 | 2003 | 2292 | 0.030 |
Why?
|
Sialyltransferases | 1 | 2012 | 75 | 0.030 |
Why?
|
Neuraminidase | 1 | 2012 | 210 | 0.030 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2012 | 177 | 0.030 |
Why?
|
Fumonisins | 1 | 2011 | 10 | 0.030 |
Why?
|
Chromatography | 1 | 2011 | 206 | 0.030 |
Why?
|
beta-Cyclodextrins | 1 | 2011 | 64 | 0.020 |
Why?
|
Toxins, Biological | 1 | 2011 | 66 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3870 | 0.020 |
Why?
|
Cell Line | 3 | 2011 | 15997 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2012 | 553 | 0.020 |
Why?
|
Neurons | 1 | 2010 | 9338 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 2010 | 73 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 12072 | 0.020 |
Why?
|
Organ Size | 1 | 2015 | 2252 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 5751 | 0.020 |
Why?
|
Perforin | 1 | 2010 | 168 | 0.020 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 109 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2012 | 1799 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2010 | 276 | 0.020 |
Why?
|
Genotype | 1 | 2003 | 12951 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14722 | 0.020 |
Why?
|
Caspase 3 | 1 | 2011 | 758 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2010 | 590 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1184 | 0.020 |
Why?
|
Prognosis | 2 | 2012 | 29063 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4776 | 0.020 |
Why?
|
Male | 4 | 2016 | 350118 | 0.020 |
Why?
|
Erythrocytes | 1 | 2015 | 2455 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2006 | 719 | 0.020 |
Why?
|
beta-Alanine | 1 | 2005 | 74 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 7149 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1990 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2010 | 1284 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2005 | 477 | 0.010 |
Why?
|
Solubility | 1 | 2005 | 1085 | 0.010 |
Why?
|
Brain | 1 | 2010 | 26385 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2005 | 689 | 0.010 |
Why?
|
Astrocytes | 1 | 2010 | 1270 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5078 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4149 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2645 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 1572 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3206 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2010 | 2455 | 0.010 |
Why?
|
Polymers | 1 | 2008 | 1621 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3798 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 17446 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3305 | 0.010 |
Why?
|
Time Factors | 2 | 2015 | 40075 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15076 | 0.010 |
Why?
|
Protein Binding | 1 | 2011 | 9386 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12797 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12788 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2005 | 2480 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 13033 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1809 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3479 | 0.010 |
Why?
|
Proteins | 1 | 2010 | 6103 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2010 | 19229 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11483 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39050 | 0.010 |
Why?
|